We are live on
!
Find out more
JF
Jump Financial Portfolio holdings
AUM
$7.5B
1-Year Est. Return
33.9%
This Fund
S&P 500
This Quarter
Est. Return
+5.18%
1 Year Est. Return
+33.9%
3 Year Est. Return
+69.87%
5 Year Est. Return
+55.07%
10 Year Est. Return
–
AUM
$1.59B
AUM Growth
+$209M
(+15%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
18.94%
Holding
1,885
New
839
Increased
299
Reduced
192
Closed
550
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$40.8M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$18.7M |
| 3 |
Microsoft
MSFT
|
+$13.2M |
| 4 |
Apple
AAPL
|
+$12.7M |
| 5 |
iShares Silver Trust
SLV
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$86.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$70.4M |
| 3 |
Direxion Daily S&P 500 Bull 3x ETF
SPXL
|
+$61.5M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$56M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$31.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.39% |
| 2 | Healthcare | 12.4% |
| 3 | Consumer Discretionary | 9.54% |
| 4 | Financials | 8.16% |
| 5 | Industrials | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Acumen Pharmaceuticals
ABOS
$155M
| $136K | 0.01% |
+20,097
| New | +$221K |
|
|
AVDL
1177
DELISTED
Avadel Pharmaceuticals
AVDL
| $136K | 0.01% |
+16,803
| New | +$154K |
|
1178
eGain
EGAN
$187M
| $136K | 0.01% |
+13,600
| New | +$141K |
|
|
ITI
1179
DELISTED
Iteris, Inc.
ITI
| $136K | 0.01% |
34,050
+19,350
| +132% | +$93.6K |
|
1180
Rithm Capital
RITM
$5.52B
| $135K | 0.01% |
12,649
-85,340
| -87% | -$952K |
|
1181
Corvus Pharmaceuticals
CRVS
$1.12B
| $134K | 0.01% |
+55,500
| New | +$215K |
|
|
ONCT
1182
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $134K | 0.01% |
+2,955
| New | +$199K |
|
1183
Orion Energy Systems
OESX
$41M
| $133K | 0.01% |
3,680
+1,770
| +93% | +$68.4K |
|
1184
Olema Pharmaceuticals
OLMA
$1B
| $133K | 0.01% |
+14,162
| New | +$293K |
|
|
BCOV
1185
DELISTED
Brightcove, Inc.
BCOV
| $133K | 0.01% |
13,000
-18,623
| -59% | -$196K |
|
1186
Stellus Capital Investment Corp
SCM
$217M
| $132K | 0.01% |
+10,100
| New | +$136K |
|
1187
Fortress Biotech
FBIO
$104M
| $131K | 0.01% |
+3,497
| New | +$156K |
|
1188
Theravance Biopharma
TBPH
$874M
| $131K | 0.01% |
+11,900
| New | +$104K |
|
1189
Amneal Pharmaceuticals
AMRX
$5.85B
| $129K | 0.01% |
26,800
+9,900
| +59% | +$49.4K |
|
1190
Antero Midstream
AM
$10.4B
| $128K | 0.01% |
+13,257
| New | +$137K |
|
1191
Old Second Bancorp
OSBC
$1.29B
| $128K | 0.01% |
10,200
-8,500
| -45% | -$112K |
|
1192
Alamos Gold
AGI
$11.6B
| $124K | 0.01% |
+16,112
| New | +$124K |
|
1193
CorMedix
CRMD
$591M
| $124K | 0.01% |
+27,400
| New | +$136K |
|
1194
Ondas Inc
ONDS
$4.27B
| $124K | 0.01% |
+18,500
| New | +$158K |
|
1195
Biomea Fusion
BMEA
$84.6M
| $123K | 0.01% |
+16,500
| New | +$174K |
|
1196
Genesis Energy
GEL
$1.87B
| $122K | 0.01% |
11,429
-11,480
| -50% | -$128K |
|
1197
Gladstone Capital
GLAD
$422M
| $122K | 0.01% |
+5,250
| New | +$121K |
|
|
FSTX
1198
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $122K | 0.01% |
+24,400
| New | +$147K |
|
1199
CuriosityStream
CURI
$145M
| $120K | 0.01% |
+20,304
| New | +$171K |
|
|
FARM
1200
DELISTED
Farmer Brothers
FARM
| $120K | 0.01% |
+16,100
| New | +$119K |
|
Similar funds
YAM
ASN
SP
AMH
BIM
CCM
GJL
DKCM
Jump Financial's Q4 2021 Portfolio in Review
As of Q4 2021, Jump Financial held 1,885 positions worth $1.59B, up 15% from $1.38B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jump Financial deployed $159M of net new capital in Q4 2021, opening 839 new positions and adding to 299 existing holdings. Its largest new stake was Meta Platforms (Facebook): 16,330 shares worth $5.49M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $86.5M trimmed.
- Jump Financial's largest Q4 2021 buy was Meta Platforms (Facebook): 16,330 shares worth $5.49M.
- Jump Financial added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $40.8M increase.
- Jump Financial's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $86.5M.
- Jump Financial fully exited State Street SPDR S&P 500 ETF Trust in Q4 2021, selling an estimated $70.4M.
- Jump Financial's ten largest holdings make up 19% of its $1.59B portfolio in Q4 2021.
- Jump Financial opened 839 new positions and closed 550 in Q4 2021.
- Jump Financial's portfolio value rose 15% quarter-over-quarter to $1.59B.
Based on Jump Financial's 13F filing for Q4 2021, filed 10 Feb 2022.